Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-03 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-03-19 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
KZIA | Kazia Therapeutics | 9.48 | 0.12 | 1.28% | 120M |
You can purchase shares of Kazia Therapeutics (NASDAQ: KZIA) through any online brokerage.
Other companies in Kazia Therapeutics’s space includes: Galectin Therapeutics (NASDAQ:GALT), CollPlant Biotechnologies (NASDAQ:CLGN) and BioLine Rx (NASDAQ:BLRX).
The latest price target for Kazia Therapeutics (NASDAQ: KZIA) was reported by HC Wainwright & Co. on 2021-01-05. The analyst firm set a price target for 17.00 expecting KZIA to rise to within 12 months (a possible 79.32% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Kazia Therapeutics (NASDAQ: KZIA) is $9.48 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Kazia Therapeutics.
There is no upcoming split for Kazia Therapeutics.